Valeo Pharma Inc
TSX:VPH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Valeo Pharma Inc
Valeo Pharma Inc
Other Current Assets
Valeo Pharma Inc
Other Current Assets Peer Comparison
TH
EDT
CPH
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Valeo Pharma Inc
TSX:VPH
|
Other Current Assets
CA$930k
|
CAGR 3-Years
25%
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Other Current Assets
$2.7m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
18%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Other Current Assets
CA$5.4m
|
CAGR 3-Years
35%
|
CAGR 5-Years
94%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Other Current Assets
CA$980k
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Other Current Assets
$419k
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
8%
|
|
V
|
Vext Science Inc
CNSX:VEXT
|
Other Current Assets
$10.9m
|
CAGR 3-Years
94%
|
CAGR 5-Years
328%
|
CAGR 10-Years
N/A
|
See Also
What is Valeo Pharma Inc's Other Current Assets?
Other Current Assets
930k
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Other Current Assets amounts to 930k CAD.
What is Valeo Pharma Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
78%
Over the last year, the Other Current Assets growth was -65%. The average annual Other Current Assets growth rates for Valeo Pharma Inc have been 25% over the past three years , 78% over the past five years .
You don't have any saved screeners yet
